Observational studyJournal of clinical hypertension (Greenwich, Conn.)2021

Single-pill combination of cilnidipine, an l-/n-type calcium channel blocker, and valsartan reduces the day-by-day variability of morning home systolic blood pressure in patients with treated hypertension: A sub-analysis of the HOPE-combi survey.

Kazuomi Kario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.